Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

Why Victoria's Secret Stock Was Soaring This Week: https://g.foolcdn.com/editorial/images/787444/happy-person-using-headphones-and-a-phone-while-lying-on-a-couch.jpg
Why Victoria's Secret Stock Was Soaring This Week

A fresh change in leadership, unexpectedly strong preliminary results, and a set of bullish new analyst notes were the main factors pushing Victoria's Secret (NYSE: VSCO) stock higher in recent

1 Growth Stock Down 43% to Buy Right Now: https://g.foolcdn.com/editorial/images/786837/continuous-glucose-monitor.jpg
1 Growth Stock Down 43% to Buy Right Now

Attractive investment opportunities can sometimes arise when investors react emotionally to short-term events. Some of these events revolve around the earnings season, when a company releases

Why Victoria's Secret Stock Was Climbing Today: https://g.foolcdn.com/editorial/images/787202/gettyimages-1729402032.jpg
Why Victoria's Secret Stock Was Climbing Today

Shares of Victoria's Secret (NYSE: VSCO) were surging today after the struggling apparel company named a new CEO, Hillary Super. Investors seem to be hopeful that the move will lead to a turnaround

RAMQ Expands Provincial Coverage to Include Dexcom G7, Bringing the Next-Generation CGM System to More Québec Residents: https://mms.businesswire.com/media/20240814728352/en/2215556/5/dexcom-g7-studio-photography-man-holding-sensor_1.jpg
RAMQ Expands Provincial Coverage to Include Dexcom G7, Bringing the Next-Generation CGM System to More Québec Residents


Dexcom, Inc. (NASDAQ: DXCM), a global leader in real-time continuous glucose monitoring (rtCGM) for people with diabetes, announced today that its latest innovation, the Dexcom G7 Continuous

EQS-News: STRATEC POSTS RESULTS FOR FIRST HALF OF 2024: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24071/375px-Stratec-Biomedical-Logo.svg.png
EQS-News: STRATEC POSTS RESULTS FOR FIRST HALF OF 2024
EQS-News: STRATEC POSTS RESULTS FOR FIRST HALF OF 2024
Should You Buy DexCom Stock After Its Post-Earnings Sell-Off?: https://g.foolcdn.com/editorial/images/785826/businessman-checking-his-phone.jpg
Should You Buy DexCom Stock After Its Post-Earnings Sell-Off?

When a stock falls over a cliff after earnings, it can put investors into an unnerving situation: Should you average down, or simply get out of the stock entirely? It's not always an easy question

These Stocks Just Dropped by 40% and 15% -- Should You Buy the Dip?: https://g.foolcdn.com/editorial/images/785566/dexcom-g6-full-family.png
These Stocks Just Dropped by 40% and 15% -- Should You Buy the Dip?

Earnings season can be a volatile time in the stock market. Some corporations produce financial results that are impressive enough to send their share prices soaring, while others move in the exact

EQS-News: First half of 2024: RHÖN-KLINIKUM AG continues good business performance – outlook confirmed: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23735/Rhoen-klinikum.svg.png
EQS-News: First half of 2024: RHÖN-KLINIKUM AG continues good business performance – outlook confirmed
EQS-News: First half of 2024: RHÖN-KLINIKUM AG continues good business performance – outlook confirmed
Humana Foundation Announces 2024 Scholarship Awards: https://mms.businesswire.com/media/20240807422403/en/2208648/5/Asia_Leach_with_mother_Yvonne_Leach.jpg
Humana Foundation Announces 2024 Scholarship Awards


The Humana Foundation, the philanthropic arm of Humana Inc. (NYSE: HUM) for the past 42 years, today announced 80 winners of college scholarships awarded through the Humana Foundation Scholarship

2 Dividend Stocks to Buy and Never Sell: https://g.foolcdn.com/editorial/images/785381/physicians-in-an-operating-room.jpg
2 Dividend Stocks to Buy and Never Sell

Every corporation will face challenges and setbacks -- which will sometimes sink its stock price. That's not a good reason for long-term investors to jump ship unless, of course, there's a

Down 40% in 1 Day, Is DexCom Stock Still a Buy?: https://g.foolcdn.com/editorial/images/785365/two-investors-look-at-figures.jpg
Down 40% in 1 Day, Is DexCom Stock Still a Buy?

July 25 was a difficult day for DexCom (NASDAQ: DXCM) shareholders, with the company's second-quarter earnings release crashing the stock by 40%. To make matters worse, at the moment it's unclear

EQS-News: Carl Zeiss Meditec closes first nine months of 2023/24 with slight decline in revenuehttp://www.meditec.zeiss.com/C125679E0051C774?Open: CARL ZEISS MEDITEC AG
EQS-News: Carl Zeiss Meditec closes first nine months of 2023/24 with slight decline in revenue
EQS-News: Carl Zeiss Meditec closes first nine months of 2023/24 with slight decline in revenue
Cigna Group (CI) Q2 2024 Earnings Call Transcript: https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template-2023-01-12.jpg
Cigna Group (CI) Q2 2024 Earnings Call Transcript

Image source: The Motley Fool.

Cigna Group (NYSE: CI)Q2 2024 Earnings CallAug 01, 2024, 8:30 a.m. ET

Operator

Continue reading

Source Fool.com

Bull Market Buys: 2 Growth Stocks to Own for the Long Run: https://g.foolcdn.com/editorial/images/784953/astonished-shocked-coffee-newspaper.jpg
Bull Market Buys: 2 Growth Stocks to Own for the Long Run

Investors who buy stocks through both bull and bear markets are the ones who tend to benefit more in the long term because they are growing their portfolios consistently. But a bull market does seem

Is The Trade Desk Stock Going to $105? 1 Wall Street Analyst Thinks So: https://g.foolcdn.com/editorial/images/785100/person-seated-at-a-desk-using-a-laptop.jpg
Is The Trade Desk Stock Going to $105? 1 Wall Street Analyst Thinks So

Next-generation digital advertising platform developer The Trade Desk (NASDAQ: TTD) is an out-of-favor stock that should be getting more investor love. That's according to one pundit following the

DexCom Stock Plunged Over 40% Last Week. Are Eli Lilly's and Novo Nordisk's Drugs to Blame?: https://g.foolcdn.com/editorial/images/785036/diabetes-cgm-man-in-wheelchair.jpg
DexCom Stock Plunged Over 40% Last Week. Are Eli Lilly's and Novo Nordisk's Drugs to Blame?

Going into 2024, DexCom's (NASDAQ: DXCM) shares were up a whopping 14 times over the last 10 years. The company's continuous glucose monitoring (CGM) devices enjoyed tremendous demand from

EQS-News: STRATEC REPORTS CHANGES IN FINANCE DIVISION: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24071/375px-Stratec-Biomedical-Logo.svg.png
EQS-News: STRATEC REPORTS CHANGES IN FINANCE DIVISION
EQS-News: STRATEC REPORTS CHANGES IN FINANCE DIVISION
AEVIS VICTORIA SA (AEVS:SW) achieved revenues of more than CHF 450 million in the first half-year 2024http://www.aevis.com: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/12720/aevis-logo.png
AEVIS VICTORIA SA (AEVS:SW) achieved revenues of more than CHF 450 million in the first half-year 2024
AEVIS VICTORIA SA (AEVS:SW) achieved revenues of more than CHF 450 million in the first half-year 2024
Why Integra Lifesciences Stock Is Sinking Today: https://g.foolcdn.com/editorial/images/785027/surgery.jpg
Why Integra Lifesciences Stock Is Sinking Today

Shares of Integra Lifesciences (NASDAQ: IART) were sinking 15.5% as of 11 a.m. ET on Monday. The decline came after the medical technology company announced its second-quarter results before the

Why Koninklijke Philips Stock Jumped 14% Today: https://g.foolcdn.com/editorial/images/785026/1-arrow-angles-up-on-a-green-stock-chart.jpg
Why Koninklijke Philips Stock Jumped 14% Today

Koninklijke Philips (NYSE: PHG) stock surged 14.5% through 10:05 a.m. ET Monday after the company reported strong earnings this morning.

Analysts had forecast the Dutch medical devices company would

2 Unstoppable Growth Stocks to Buy Right Now for Less Than $1,000: https://g.foolcdn.com/editorial/images/784337/listening-laptop-podcast-smiling-happy.jpg
2 Unstoppable Growth Stocks to Buy Right Now for Less Than $1,000

Bull markets come and go, and give way to bear markets, and come back again. The stock market has a remarkable habit of steadily rising with the passage of time. For investors who stay invested

2 Magnificent Growth Stocks to Buy Right Now: https://g.foolcdn.com/editorial/images/784339/man-reading-paper-report-statement-and-using-laptop.jpg
2 Magnificent Growth Stocks to Buy Right Now

Not all stocks have responded to the bull market in the some way. While many businesses have followed the broader trend of steadily rising, some stocks are trading down considerably and even coming

Marjorie Taylor Greene Loves Vanguard ETFs; Here Are 4 She Bought in the First Half of 2024: https://g.foolcdn.com/editorial/images/783942/washington-dc-the-pencil-monument-cherry-blossom-1200x800-5b2df79.jpg
Marjorie Taylor Greene Loves Vanguard ETFs; Here Are 4 She Bought in the First Half of 2024

Sure, how politicians vote on legislation and what they say on the campaign trail are the stuff of intense scrutiny. But that's not the only thing people are following with today's pols.

Retail

Centene (CNC) Q2 2024 Earnings Call Transcript: https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template-2023-01-12.jpg
Centene (CNC) Q2 2024 Earnings Call Transcript

Image source: The Motley Fool.

Centene (NYSE: CNC)Q2 2024 Earnings CallJul 26, 2024, 8:30 a.m. ET

Operator

Continue reading

Source Fool.com

Why DexCom Stock Is Crashing Today: https://g.foolcdn.com/editorial/images/784772/dexcom-cgm-devices-and-apps.png
Why DexCom Stock Is Crashing Today

Shares of DexCom (NASDAQ: DXCM) were crashing 39.9% lower as of 10:20 a.m. ET on Friday. The huge sell-off came after the continuous glucose monitoring (CGM) systems maker announced its